NCT01126970View on ClinicalTrials.gov

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

486

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions
Obesity
Interventions
DRUG

Velneperit 400 mg

Velneperit 400 mg q.d.

DRUG

Orlistat 120 mg

Orlistat 120 mg t.i.d

DRUG

Orlistat Placebo

Orlistat Placebo t.i.d.

DRUG

Velneperit Placebo

Velneperit Placebo q.d

OTHER

Reduced Calorie Diet

Reduced calorie diet

Trial Locations (25)

Unknown

Santa Rosa

Waterbury

Clearwater

Jacksonville

Ocala

Ponte Vedra

Augusta

Louisville

Boston

Milford

North Dartmouth

St Louis

Lincoln

Albuquerque

Manlius

Rochester

Cary

Raleigh

Cleveland

Columbus

Greenville

Nashville

New Braunfels

Renton

Wauwatosa

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY